Evidence map›Paper›PMID 34741130›Full record

ArticleMolecular psychiatry2022

Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia.

Anaamika Campeau, Robert H Mills, Toer Stevens, Leigh-Ana Rossitto, Michael Meehan, Pieter Dorrestein, Rebecca Daly, Tanya T Nguyen, David J Gonzalez, Dilip V Jeste and 1 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Schizophrenia: from mechanism to therapy.Science China. Life sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anaamika CampeauDepartment of Pharmacology, University of California, San Diego, CA, 92093, USA.
Robert H MillsDepartment of Pharmacology, University of California, San Diego, CA, 92093, USA.
Toer StevensAmsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Leigh-Ana RossittoDepartment of Pharmacology, University of California, San Diego, CA, 92093, USA.ORCID http://orcid.org/0000-0002-7744-3630
Michael MeehanSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA, 92093, USA.
Pieter DorresteinDepartment of Pharmacology, University of California, San Diego, CA, 92093, USA.ORCID http://orcid.org/0000-0002-3003-1030
Rebecca DalySam and Rose Stein Institute for Research on Aging, University of California, San Diego, CA, 92093, USA.
Tanya T NguyenSam and Rose Stein Institute for Research on Aging, University of California, San Diego, CA, 92093, USA.
David J Gonzalez *Department of Pharmacology, University of California, San Diego, CA, 92093, USA. djgonzalez@ucsd.edu.ORCID http://orcid.org/0000-0003-1423-5970
Dilip V Jeste *Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, CA, 92093, USA.
Vivian Hook *Department of Pharmacology, University of California, San Diego, CA, 92093, USA.

Funding

Project 4 - Mechanistic studies on the role of the gut microbiome in models for Alzheimer's diseaseU19AG063744 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ROB KNIGHT, Rima F Kaddurah-Daouk · 2019 to 2026
$54.1M
GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Rheumatic Diseases Research Training GrantT32AR064194 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GARY S FIRESTEIN, Monica Guma · 2013 to 2026
$3.8M
Role of Human-Specific Cathepsin V Protease in the Production of Opioid and Related Peptide NeurotransmittersR01NS094597 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H · 2015 to 2019
$1.7M
Characterizing the gut microbiome in schizophrenia: Relationship to age, cognition, & disease-related factorsK23MH118435 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NGUYEN, TANYA T · 2019 to 2020
$375k
NIAMS NIH HHS T32 AR064194NIA NIH HHS U19 AG063744NIGMS NIH HHS T32 GM007752NIMH NIH HHS K23 MH118435NINDS NIH HHS R01 NS094597
6 · The paper itself

Abstract

Schizophrenia is a devastating psychiatric illness that detrimentally affects a significant portion of the worldwide population. Aging of schizophrenia patients is associated with reduced longevity, but the potential biological factors associated with aging in this population have not yet been investigated in a global manner. To address this gap in knowledge, the present study assesses proteomics and metabolomics profiles in the plasma of subjects afflicted with schizophrenia compared to non-psychiatric control patients over six decades of life. Global, unbiased analyses of circulating blood plasma can provide knowledge of prominently dysregulated molecular pathways and their association with schizophrenia, as well as features of aging and gender in this disease. The resulting data compiled in this study represent a compendium of molecular changes associated with schizophrenia over the human lifetime. Supporting the clinical finding of schizophrenia's association with more rapid aging, both schizophrenia diagnosis and age significantly influenced the plasma proteome in subjects assayed. Schizophrenia was broadly associated with prominent dysregulation of inflammatory and metabolic system components. Proteome changes demonstrated increased abundance of biomarkers for risk of physiologic comorbidities of schizophrenia, especially in younger individuals. These findings advance our understanding of the molecular etiology of schizophrenia and its associated comorbidities throughout the aging process.

Indexed as

SchizophreniaAgingHumansInflammationPlasmaProteomeProteome

Identifiers

PMID34741130
PMCPMC9054664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.